{"database": "lobbying", "table": "lobbying_activities", "rows": [[3962934, "a8761bc0-c645-4f4c-a484-ab5ee1481b2e", "Q2", "WILLOW LABORATORIES", 401109834, "WILLOW LABORATORIES", 2026, "second_quarter", "MMM", "Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2026-06-18T08:36:18-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3962934"], "units": {}, "query_ms": 0.20059701637364924, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}